Dermatology biotech Menlo Therapeutics sets terms for $85 million IPO - (Nasdaq via NewsPoints Desk)

• Menlo Therapeutics, which develops therapies for dermatological indications, announced plans to raise $85 million by offering 5.7 million shares at a price range of $14 to $16 in an initial public offering, reported Nasdaq.

• Insiders intend to purchase $40 million worth of shares in the offering, the news source said.

• FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.